!!Jorge Moscat
\\
[Long CV|[moscat_jorge_2013_CV.pdf]
\\ \\
__Citizenship:__ Spanish, US Permanent Resident (Green Card holder)\\
__Marital Status:__ Married, 2 children\\
__Present Position:__ Professor and Chairman, Department of Cancer and Cell Biology, University of Cincinnati College of Medicine\\
\\	
__Education:__
\\
*1975-1980 BS in Biochemistry, Universidad Complutense, Madrid	
*1981-1984 PhD in Biochemistry and Molecular Biology, Universidad Complutense, Madrid
\\
__Brief Chronology of Employment:__
\\
*1983-1985,	Researcher, Department of Internal Medicine, Hospital Clinico San Carlos, Madrid
*1985-1990  	Group Leader, Department of Experimental Medicine, Hospital Gregorio Marañón, Madrid
*1987&1988 	Guest Researcher, Laboratory of Cellular and Molecular Biology, National Cancer Institute, NIH,  Bethesda, Maryland
*1990-1993	Research Scientist (CSIC)
*1993-		Research Professor (CSIC), on Special Leave since July 2006
*1996-2000	Director Laboratory GlaxoWellcome-CSIC of Molecular and Cellular Biology
*1998-2002	Director of the Instituto de Biología Molecular (CSIC)
*2004-2006	Scientific Coordinator of the Biology and Biomedicine Institutes of the Spanish National Research Council (CSIC)
*2006-2008	Professor, Department of Genome Science, University of Cincinnati College of Medicine
*2007-2008	Interim Chairman, Department of Genome Science/Molecular Oncogenesis, University of Cincinnati College of Medicine
*2008-		Professor and Chairman, Department of Cancer and Cell Biology, University of Cincinnati College of Medicine
*2008-2011	Associate Director, University of Cincinnati Cancer Center
*2011-	Professor, NCI-Cancer Center, Sanford-Burnham Medical Research Institute
*2012-	Scientific Director, Cancer Metabolism, Sanford-Burnham Medical Research Institute
*2013-	Director, Cell Death and Survival Networks Program, NCI-Cancer Center, Sanford-Burnham Medical Research Institute
*2013-	Adjunct Professor, Department of Pharmacology, School of Medicine, University of California San Diego
\\
__Honours and Awards:__
\\
*1980	Undergraduate Fellowship from Le Petit Pharmaceutical Laboratories (Dow Chemical Co.)
*1981	Postgraduate Fellowship from the Spanish Education and Science Ministry   
*1982	Postgraduate Fellowship from the Spanish National Institute of Health
*1984	Short-term Fellowship from Spanish Health Ministry, for studies in the Institute of Pharmacology "Mario Negri", Milano, Italy
*1985 & 1986	Short-term Fellowships from the British Council to work at the Department of Biochemistry, AFRC Institute of Animal Physiology, Cambridge, U.K.    
*1987	Long-term Fellowship from "Juan March" Foundation to work at the National Cancer Institute, NIH, Bethesda, USA
*1989 & 1991 Awards of the Spanish Cancer Scientific Association
*1995 Elected member of the European Molecular Biology Organization (EMBO)
*1998 Award of the Foundation for Health Sciences
*1999 Award of the Spanish Royal Academy of Sciences
*2000 Award of the Carmen and Severo Ochoa Foundation
*2001 Award of the Juan March Foundation
*2002 Member of the Editorial Board of EMBO Journal 
*2002 Member of the Editorial Board of EMBO Reports
*2006 Elected Member of the Academia Europaea 
*2010-2012 Ad hoc member of NIH Cancer Molecular Pathobiology and Cancer Etiology Study Sections
*2010 Member review panel NCI Cancer and Inflammation Program
*2011 Member panel on NCI Provocative Questions (Salk Institute, La Jolla)
*2012 - Permanent member of NIH Cancer Etiology Study Section
*2012 Ad hoc member NIH Tumor Cell Biology Study Section
*2012 - Member of the Scientific Advisory Board of the Institute for Diabetes and Obesity of the 		Helmholtz Zentrum München (Germany)
\\
__Main International Seminars__
\\
*Invited Speaker, Children's Hospital, Boston 1990
*Invited Speaker, Harvard Medical School, Boston 1991
*Invited Speaker, Glaxo U.K, London 1994
*Invited Speaker, Chester Beatty Laboratories, London 1995
*Invited Speaker, EMBL, Heidelberg 1995 
*Invited Speaker, Friedrich Miescher-Institut, Basel 1995
*Invited Speaker, Dana Farber Cancer Institute, Boston 1995
*Invited Speaker, Tularik Inc., San Francisco 1996
*Invited Speaker, Glaxo-Wellcome U.K., Stevenage 1996
*Invited Speaker, Glaxo-Wellcome USA, RTP 1996
*Invited Speaker, National Cancer Institute, NIH, Bethesda 1996
*Invited Speaker, Friedrich Miescher-Institut, Basel 1997
*Invited Speaker, Mayo Clinic, Rochester Minnesota 1998
*Invited Speaker, Albert Einstein College of Medicine, New York 1999
*Invited Speaker, University of Virginia at Charlottesville, Virginia 2000
*Invited Speaker, Gent University, Gent 2000
*Invited Speaker, University of Illinois at Chicago, Chicago 2001
*Invited Speaker, Pfizer USA, Groton 2002
*Invited Speaker, Wyeth USA, Boston 2002
*Invited Speaker, Biogen Inc., Boston 2002
*Invited Speaker, University of Pittsburgh Medical Center, Pittsburgh 2002
*Invited Speaker, Institut de Biologie Moléculaire et Cellulaire-CNRS, Strasbourg 2003
*Invited Speaker, Cancer Center of the University of Illinois at Chicago 2003
*Invited Speaker, Pfizer USA, Saint Louis 2003
*Invited Speaker, Biogen-Idec, Boston 2004
*Invited Speaker, University of Cincinnati, Cincinnati 2005
*Invited Speaker, Cincinnati Children’s Hospital, Cincinnati 2006
*Invited Speaker, Washington University School of Medicine, Saint Lous 2007
*Invited Speaker, Brown University, Providence 2007
*Invited Speaker, Ohio State University Cancer Center, Columbus 2007
*Invited Speaker, Genentech, San Francisco 2009
*Invited Speaker, Harvard, Boston 2010
*Invited Speaker, Sanford-Burnham Medical Research Institute, San Diego 2010
*Invited Speaker, Indiana University, Indianapolis, 2010
*Invited Speaker, Spanish National Cancer Institue (CNIO), Madrid, 2010
*Invited Speaker, National Center of Biotechnology, Madrid, 2010
*Invited Speaker, Centre of Molecular Biology Severo Ochoa, Madrid, 2010
*Invited Speaker, Spanish National Cardiovascular Institute (CNIC), Madrid 2011
*Invited Speaker, University of California San Diego, 2012
*Invited Speaker, University of California Riverside, 2012
*Invited Speaker, University of California Davis, 2012
*Invited Speaker, University of California Santa Barbara, 2012
*Invited Speaker, Stony Brook Cancer Center, NY, 2013
*Invited Speaker, Loyola University School of Medicine, Chicago, 2013
*Invited Speaker, NIH-Frederick, Washington DC, 2013
*Invited Speaker, University of Southern California, Los Angeles, 2013
*Invited Speaker, University of California San Diego, Dept. Pharmacology, 2013
*Invited Speaker, University of California San Diego, Dept. Bioengineering, 2013
*Invited Speaker, Case Western Reserve, Cleveland, 2013


\\